Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer.

Lee, Nancy Y; Morris, Luc G T; Diehn, Maximilian

Lee, Nancy Y; Morris, Luc G T; Diehn, Maximilian.

Afiliación

Lee NY; Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Morris LGT; Immunogenomics and Precision Oncology Platform, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Diehn M; Stanford University, Stanford, California.

JAMA Oncol ; 2024 Jun 27.

Article en En | MEDLINE | ID: mdl-38935364

This Viewpoint evaluates the use of tumor tissuemodified human papillomavirus (HPV) DNA in identifying minimal residual disease.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JAMA Oncol Año: 2024 Tipo del documento: Article